Colorectal Health Research Champions for Cancer of Colon

Phase-Based Estimates
1
Effectiveness
1
Safety
Virginia Commonwealth University, Richmond, VA
Cancer of Colon+3 More
Colorectal Health Research Champions - Behavioral
Eligibility
18+
All Sexes
Eligible conditions
Cancer of Colon

Study Summary

This study is evaluating whether a program which provides information to community members about colorectal cancer may help increase participation in research.

See full description

Eligible Conditions

  • Cancer of Colon
  • Colonic Neoplasms
  • Cancer of Rectum
  • Rectal Neoplasms

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Colorectal Health Research Champions will improve 2 primary outcomes in patients with Cancer of Colon. Measurement will happen over the course of 4 months.

4 months
Increase in knowledge and intentions related to biospecimen donation and clinical trial participation.
Increase in participants knowledge and intentions related to colorectal cancer screening.

Trial Safety

Safety Estimate

1 of 3

Trial Design

2 Treatment Groups

Control
Colorectal Health Research Champion trainees

This trial requires 400 total participants across 2 different treatment groups

This trial involves 2 different treatments. Colorectal Health Research Champions is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Colorectal Health Research Champion trainees
Behavioral
Colorectal Health Research Champion (CHRC) trainees receive 5 education sessions on colorectal cancer, clinical research, biospecimen donation, ethics, and presentation skills. The CHRCs will invite others in their social networks to present to them this educational information, following the train the trainer model of health education.
ControlNo treatment in the control group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 4 months for reporting.

Closest Location

Virginia Commonwealth University - Richmond, VA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
They have been directly or indirectly impacted by colorectal cancer and are interested in becoming a champion for colorectal cancer research. show original
The person is over the age of 30. show original
They are literate
An adult of any gender is someone who is no longer a child. show original
more than 30 years old. show original

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the chances of developing cancer of colon?

Add answer

Individuals with both a low PSA level and previous endoscopic treatment of colon polyps have a relatively high risk of developing [colon cancer](https://www.withpower.com/clinical-trials/colon-cancer). Individuals with colorectal cancer should have a repeat PSA test at 6mo. The risks of developing cancer of colon are similar for both men and women.

Unverified Answer

What are the signs of cancer of colon?

Add answer

Most cases of [colon cancer](https://www.withpower.com/clinical-trials/colon-cancer) that are detected in people over 65 are adenomas and not cancers. This is probably because they are detected later than cancers of the rectum and anus. Older age is often a good indicator of detecting colon cancer, but this cancer is also related to a high dietary fat and low fibre diet. Smoking is also a risk factor. Some cases are detected because they cause bleeding or pain and hence they are identified during screening.

Unverified Answer

What causes cancer of colon?

Add answer

The development of colorectal cancer may be caused by a variety of factors including hereditary conditions and diets. Tobacco use is one of the greatest risk factors for colon cancer. The diagnosis of colon cancer may cause the person to question normal values of diet, hygiene, exercise, and colonoscopy.

Unverified Answer

What are common treatments for cancer of colon?

Add answer

The treatments that treat people with [colorectal cancer](https://www.withpower.com/clinical-trials/colorectal-cancer) can be classified into specific groups, namely chemotherapy, radiation therapy, and surgery. While chemotherapy and radiation therapy have a significant impact in terms of a cure rates, surgical intervention plays a major role by making the treatment effective even in a case of local-recurrence for people with colorectal cancer. It can be seen in statistics that people, as they get older, are suffering from a higher rates of colorectal cancer that results in a better survivability rate on a long-term period despite of the risks incurred in a cancer surgeries. [cite (1) Schillberg, P. (2006).

Unverified Answer

How many people get cancer of colon a year in the United States?

Add answer

About 33,300 new cases of colon cancer are expected to be diagnosed in the United States in 2000, which equals 8.7% of all diagnoses of colorectal cancer. This would be up from 11.6% of colorectal cancer diagnoses in 2000, and is 2.8% higher than the proportion attributed to colon cancer. Over the next 20 years, we expect to have an annual increase in colorectal cancer of 9.8% and a 4.2% increase in colon cancer-related deaths. From 1979-1999 the number of new cases of colorectal cancer increased 8.

Unverified Answer

Can cancer of colon be cured?

Add answer

Findings from a recent study showed that patients can expect a cure from treatment of colon cancer in nearly three quarters of matched cohort cases. However our results do not show that any patient can expect cure with either surgery or chemotherapy in the absence of chemotherapy or surgery.

Unverified Answer

What is cancer of colon?

Add answer

Cancer of colon is an incurable condition that is treated with curative intent, using either surgery or radiation therapy. Preventive oncology is another major focus of cancer research in the US.

Unverified Answer

What is the survival rate for cancer of colon?

Add answer

There is a very clear survival advantage for patients with left-sided colorectal cancer who undergo resections for curative purposes. Survival time of patients who underwent right-sided resections was significantly shorter at the end of the study period.

Unverified Answer

Is colorectal health research champions typically used in combination with any other treatments?

Add answer

There is no evidence that CHRC are typically used in combination with any other treatments in clinical practice, but it is not uncommon to use CHRC as part of an integral approach in a patient's management.

Unverified Answer

What are the latest developments in colorectal health research champions for therapeutic use?

Add answer

Current clinical trials have found that immunostimulants are effective in treating [cancer of the colon]. Ongoing trials have confirmed previous findings, and several compounds have shown efficacy when compared with placebo in well-defined subgroups with well-characterized prognostic factors after resection of primary tumours. Although there are some disadvantages to therapeutic use, the results of these clinical trials are encouraging and may lead to a shift in thinking from palliative care towards curative care.

Unverified Answer

How does colorectal health research champions work?

Add answer

The findings of this study indicate that, in terms of the characteristics of this sample of health professionals, the work of community health champions varied considerably from one individual to another but that, despite this variability, the CHCs were generally able to function effectively as a resource for the study.

Unverified Answer

What are the common side effects of colorectal health research champions?

Add answer

Most respondents to this study preferred to complete clinical trial reporting guidelines in order to minimize the impact that potential side effects might have on clinical trial conclusions on their treatment. Physicians and participants in the current study have a keen interest in being informed of these side effects, but they are not aware of all the side effects associated with colorectal cancer treatments. The fact that they are more widely accessible, such as in reporting guidelines, may be one reason why colorectal cancer is a disease whose treatment side effects are poorly understood. Efforts to increase the number of participants using the reporting guideline are needed.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Cancer of Colon by sharing your contact details with the study coordinator.